Announce Date | 05/06/2025 |
EPS Normalized Actual | $0.65 (Beat by $0.06) |
EPS GAAP Actual | $0.65 (Beat by $0.06) |
Revenue Actual | $2.0048B |
Revenue Surprise | Beat by $2004.8M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $2.16049 |
EPS GAAP Estimate | $2.16049 |
Revenue Estimate | $1.888020592B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 4.60334 | 21.49 | 4.43029 | 4.95115 | 5 |
Dec 2027 | 12.3 | 8.04 | 11.82794 | 13.1431 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.65 | -1.39549 | 2.0048B | 21.62% | 215.71M |
FQ4 2024 (Dec 2024) | 0.64 | 0.64 | 1.93044B | 20.2% | 1930.44M |
FQ3 2024 (Sep 2024) | 2.38 | 2.38 | 1.81094B | 16.65% | 1810.94M |
FQ4 2012 (Dec 2012) | 0.028 | 0.028 | 0.057341B | 100% | 57.34M |
FQ2 2024 (Jun 2024) | 2.12 | 2.12 | 1.6904B | 13.69% | 1690.4M |
FQ1 2024 (Mar 2024) | 2.04 | 2.04 | 1.57137B | 14% | 1571.37M |
FQ4 2023 (Dec 2023) | 1.98 | 1.98 | 1.54044B | 17.2% | 1540.44M |
FQ3 2023 (Sep 2023) | 1.76 | 1.76 | 1.50946B | 22.04% | 1509.46M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
2.16049
Consensus Revenue Estimates
1.888020592B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.87852 | -- | 0.84591 | 0.93125 | 6 |
FQ2 2027 (Jun 2027) | 0.83377 | -- | 0.80282 | 0.88382 | 6 |
FQ1 2027 (Mar 2027) | 0.79543 | -- | 0.7659 | 0.84318 | 6 |
FQ4 2026 (Oct 2026) | 2.53392 | -- | 2.4618 | 2.68052 | 6 |
FQ3 2026 (Jul 2026) | 2.49628 | -- | 2.42523 | 2.6407 | 11 |
FQ2 2026 (Jun 2026) | 2.35131 | -- | 2.28717 | 2.47389 | 11 |
FQ1 2026 (Mar 2026) | 2.2594 | 71.23 | 2.19776 | 2.37719 | 6 |
FQ4 2025 (Oct 2025) | 2.27538 | 71.87 | 2.21062 | 2.40702 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 2.72B | -- | 2.64B | 2.84B | 8 |
FQ2 2027 (Jun 2027) | 2.62B | -- | 2.55B | 2.74B | 7 |
FQ1 2027 (Mar 2027) | 2.49B | -- | 2.42B | 2.6B | 10 |
FQ4 2026 (Oct 2026) | 2.2B | -- | 2.15B | 2.29B | 6 |
FQ3 2026 (Jul 2026) | 2.12B | -- | 2.07B | 2.22B | 6 |
FQ2 2026 (Jun 2026) | 2.09B | -- | 2.04B | 2.17B | 12 |
FQ1 2026 (Mar 2026) | 2.02B | 0.62 | 1.98B | 2.1B | 7 |
FQ4 2025 (Oct 2025) | 1.98B | 2.59 | 1.94B | 2.07B | 10 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.04549 | 0.65 | -1.39549 | -214.69% |
FQ4 2024 (Dec 2024) | 0.64 | 0.64 | 100% | |
FQ3 2024 (Sep 2024) | 2.38 | 2.38 | 100% | |
FQ4 2012 (Dec 2012) | 0.028 | 0.028 | 100% | |
FQ2 2024 (Jun 2024) | 2.12 | 2.12 | 100% | |
FQ1 2024 (Mar 2024) | 2.04 | 2.04 | 100% | |
FQ4 2023 (Dec 2023) | 1.98 | 1.98 | 100% | |
FQ3 2023 (Sep 2023) | 1.76 | 1.76 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $1.79B | $2B | $215.71M | 10.76% |
FQ4 2024 (Dec 2024) | $0B | $1.93B | $1930.44M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.81B | $1810.94M | 100% |
FQ4 2012 (Dec 2012) | $0B | $0.06B | $57.34M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.69B | $1690.4M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.57B | $1571.37M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.54B | $1540.44M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.51B | $1509.46M | 100% |